The World Economic Outlook (WEO) database contains selected macroeconomic data series from the statistical appendix of the World Economic Outlook report, which presents the IMF staff's analysis and ...

Bob Iger says AI will give viewers ‘the opportunity to create on our platforms.’ Bob Iger says AI will give viewers ‘the opportunity to create on our platforms.’ is a news writer who covers the ...

Boy, Disney continues to be the villain. They have proven time and again that, despite their outward appearance of hopeful art for the whole family, the House of Mouse has but one priority and that is ...

Disney CEO Bob Iger hinted at "productive conversations" with unnamed AI companies that would protect IP but add new features to the studio's flagship streaming service. By Tony Maglio Don’t want to ...

Disney+ subscribers could soon be getting “game-like features” in the not too distant future, and it has artificial intelligence (AI) to thank, according to Bob Iger. The media giant is also looking ...

The Trump administration stopped updating a database tracking the costs of the country’s worst disasters. A group of scientists has revived it. By Scott Dance The Trump administration this year ...

If you feel overwhelmed or stuck in a close relationship, therapist KC Davis, author of Who Deserves Your Love, has a list of questions to help you decide whether you should continue to engage. Davis ...

It would help a lot in a transition from oracle to IvorySQL if sqlplus would be supported in one or the other way. Even getting the 90% done would be a great help. I was parsing the context into a ...

Hundreds of people who were once detained at the troubled immigration jail in the Florida Everglades, dubbed “Alligator Alcatraz,” have disappeared. Democracy Now! speaks with Shirsho Dasgupta, a ...

Microsoft is betting big on this class of laptops with built-in AI processing. Here's what sets these systems apart right now. I've been testing PC and mobile software for more than 20 years, focusing ...

Vertex Pharmaceuticals is offering Enlaza Therapeutics more than $2 billion in biobucks through a multitarget drug discovery deal aiming to create new T-cell engagers and small-format drug conjugates.